Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Dr. med. Kerstin Herzer

Funktionen

  • Privatdozent/in, Zentrum für Chirurgie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Dehnen, Dorothea; Milzkott, Maia; Borchardt, Benjamin; Graute, Anette; Dehnen, Katja; Herzer, Kerstin; Willuweit, Katharina; Herwig, Anna; Rashidi Alavijeh, Jassin; Weltermann, Birgitta
    Effectiveness of a Personal Vaccination Recommendation Letter to Liver Transplant Patients and Family Physicians for Improving the Vaccination Status: Improving Vaccinations : Whom to Contact?
    In: Clinical Transplantation, Jg. 39, 2025, Nr. 10, e70239
    DOI (Open Access)
  • Gliga, Smaranda; Fiedler, Melanie; Dornieden, Theresa; Achterfeld, Anne; Paul, Andreas; Horn, Peter; Herzer, Kerstin; Lindemann, Monika
    Comparison of three cellular assays to predict the course of CMV infection in liver transplant recipients
    In: Vaccines, Jg. 9, 2021, Nr. 2, S. 88
    DOI, Online Volltext (Open Access)
  • Wedemeyer, Heiner; Herzer, Kerstin; Serfert, Yvonne; Taubert, Richard; Trautwein, Christian; Eurich, Dennis; Strassburg, Christian P.; Lang, Melanie; Weiss, Karl Heinz; Berg, Thomas; Galle, Peter R.; Heinzow, Hauke; Zeuzem, Stefan
    Declining Numbers of Hepatitis C Virus-Associated Liver Transplantations in Germany
    In: Deutsches Ärzteblatt International, Jg. 118, 2021, Nr. 46, S. 797 – 798
    DOI (Open Access)
  • Rashidi-Alavijeh, Jassin; Crämer, Jens Christoph; Sauter, Helena Louisa; Willuweit, Katharina; Straub, Katja; Wedemeyer, Heiner; Herzer, Kerstin
    Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplant
    In: Transplant Infectious Disease, Jg. 23, 2021, Nr. 3, e13553
    DOI (Open Access)
  • Willuweit, Katharina; Frey, Alexandra; Hörster, Anne; Saner, Fuat; Herzer, Kerstin
    Real-World Administration of Once-Daily MeltDose® Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
    In: Journal of Clinical Medicine (JCM), Jg. 10, 2021, Nr. 1, 124
    DOI, Online Volltext (Open Access)
  • Rashidi-Alavijeh, Jassin; Straub, Katja; Achterfeld, Anne; Wedemeyer, Heiner; Willuweit, Katharina; Herzer, Kerstin
    Safety and efficacy of tenofovir alafenamide in liver transplant recipients : A single center experience
    In: Transplant Infectious Disease, Jg. 23, 2021, Nr. 3, S. e13522
    DOI (Open Access)
  • Herzer, Kerstin; Sterneck, Martina; Welker, Martin-Walter; Nadalin, Silvio; Kirchner, Gabriele; Braun, Felix; Malessa, Christina; Herber, Adam; Pratschke, Johann; Weiss, Karl Heinz; Jaeckel, Elmar; Tacke, Frank
    Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany
    In: Journal of Clinical Medicine (JCM), Jg. 9, 2020, Nr. 11, 3570
    DOI (Open Access)
  • Knop, Viola; Mauss, Stefan; Goeser, Tobias; Geier, Andreas; Zimmermann, Tim; Herzer, Kerstin; Postel, Nils; Friedrich-Rust, Mireen; Hofmann, Wolf Peter; German Hepatitis C‐Registry
    Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy : Results from the German Hepatitis C-Registry
    In: Journal of Viral Hepatitis, Jg. 27, 2020, Nr. 7, S. 690 – 698
    DOI
  • Willuweit, Katharina; Frey, Alexandra; Bieniek, Lisa; Heinold, Andreas; Büchter, Matthias; Horn, Peter; Wedemeyer, Heiner; Herzer, Kerstin
    HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level
    In: BMC Gastroenterology, Jg. 20, 2020, Nr. 1, S. 288
    DOI, Online Volltext (Open Access)
  • Gerken, Guido; Walker, Andreas; Timm, Jörg; Frey, Alexandra; Wedemeyer, Heiner; Herzer, Kerstin
    An mTor-based immunosuppression reduces the antiviral efficacy of NS3/4A and NS5A inhibitors for HCV genotype 1b treatment in vitro
    In: Journal of Hepatology, Jg. 70, 2019, Nr. 1 Suppl., S. e829
    DOI
  • Wedemeyer, Heiner; Herzer, Kerstin; Hörster, Anne; Saner, Fuat; Frey, Alexandra
    Application of an extended-release tacrolimus formulation allows dose reduction and stabilizes graft function after liver transplantation
    In: Journal of Hepatology, Jg. 70, 2019, Nr. 1 Suppl., S. e557 – e558
    DOI
  • Willuweit, Katharina; Bezinover, Dmitri; Herzer, Kerstin; Nowak, Knut M.; Paul, Andreas; Saner, Fuat
    Efficacy of IgM-enriched Immunoglobulin for Vasopressor-resistant Vasoplegic Shock After Liver Transplantation
    In: Transplantation, Jg. 103, 2019, Nr. 2, S. 381 – 386
    DOI (Open Access)
  • Dehnen, Dorothea; Herwig, Anna; Herzer, Kerstin; Weltermann, Birgitta
    Improving the vaccination status of liver transplant patients : Effectiveness of personally addressing patients and written recommendations to family physicians after 3 years
    In: Transplant Infectious Disease, Jg. 21, 2019, Nr. 5, S. e13140
    DOI (Open Access)
  • Kaulfuß, M.; Herzer, Kerstin; Witzke, Oliver
    KDIGO-Leitlinie zu Prävention, Diagnostik, Evaluation und Therapie der Hepatitis-C-Virus-Infektion bei chronischer Nierenerkrankung : Deutsche Übersetzung und Kurzfassung
    In: Der Nephrologe, Jg. 14, 2019, Nr. 1, S. 46 – 50
    DOI
  • Straub, Katja; Husen, Peri; Baba, Hideo Andreas; Trippler, Martin; Wedemeyer, Heiner; Herzer, Kerstin
    Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice
    In: Cancer Medicine, Jg. 8, 2019, Nr. 8, S. 3793 – 3802
    DOI, Online Volltext (Open Access)
  • Husen, Peri; Straub, K.; Willuweit, Katharina; Hagemann, Anna; Wedemeyer, Heiner; Bachmann, Hagen Sjard; Herzer, Kerstin
    SNPs Within the MTOR Gene Are Associated With an Increased Risk of Developing De Novo Diabetes Mellitus Following the Administration of Everolimus in Liver Transplant Recipients
    In: Transplantation Proceedings, Jg. 51, 2019, Nr. 6, S. 1962 – 1971
    DOI
  • Friebus-Kardash, Justa; Gäckler, Anja; Kribben, Andreas; Witzke, Oliver; Wedemeyer, Heiner; Treckmann, Jürgen-Walter; Herzer, Kerstin; Eisenberger, Ute
    Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients
    In: Transplant Infectious Disease, Jg. 21, 2019, Nr. 5, S. e13146
    DOI (Open Access)
  • Bedreli, Sotiria; Straub, Katja; Achterfeld, Anne; Willuweit, Katharina; Katsounas, Antonios; Saner, Fuat; Wedemeyer, Heiner; Herzer, Kerstin
    The Effect of Immunosuppression on Coagulation After Liver Transplantation
    In: Liver Transplantation, Jg. 25, 2019, Nr. 7, S. 1054 – 1065
    DOI
  • Eisenberger, Ute; Friebus-Kardash, Justa; Guberina, Hana; Kribben, Andreas; Witzke, Oliver; Willuweit, Katharina; Gerken, Guido; Herzer, Kerstin
    Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function.
    In: Transplantation Direct, Jg. 5, 2019, Nr. 1, S. e419
    DOI, Online Volltext (Open Access)
  • Herzer, Kerstin; Eisenberger, Ute
    Verwendung HBV- oder HCV-infizierter Spenderorgane bei der Leber- und Nierentransplantation
    In: Der Gastroenterologe, Jg. 14, 2019, Nr. 4, S. 260 – 268
    DOI
  • Herzer, Kerstin; Gerken, Guido; Kroy, Daniela; Tacke, Frank; Plewe, Julius; Eurich, Dennis; Spengler, Ulrich; Strassburg, Christian P.; Welker, Martin-Walter; Pischke, Sven; Sterneck, Martina; Mehrabi, Arianeb; Weiss, Karl Heinz; Herber, Adam; Berg, Thomas; Zimmermann, Tim; Galle, Peter R.; Heinzow, Hauke; Schmidt, Hartmut; Markova, Antoaneta; Serfert, Yvonne; Manns, Michael P.; Zeuzem, Stefan; Wedemeyer, Heiner
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany
    In: Journal of Hepatology, Jg. 69, 2018, Nr. 4, S. 982 – 984
    DOI (Open Access)
  • Beckebaum, Susanne; Herzer, Kerstin; Bauhofer, Artur; Gelson, William; De Simone, Paolo; de Man, Robert; Engelmann, Cornelius; Müllhaupt, Beat; Vionnet, Julien; Salizzoni, Mauro; Volpes, Riccardo; Ercolani, Giorgio; De Carlis, Luciano; Angeli, Paolo; Burra, Patrizia; Dufour, Jean-François; Rossi, Massimo; Cillo, Umberto; Neumann, Ulf; Fischer, Lutz; Niemann, Gabriele; Toti, Luca; Tisone, Guiseppe
    Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
    In: Annals of Transplantation, Jg. 23, 2018, S. 789 – 801
    DOI (Open Access)
  • Herzer, Kerstin; Frey, Alexandra; Walker, Andreas; Timm, Jörg; Gerken, Guido; Piras-Straub, Katja
    The influence of immunosuppressants on direct-acting antiviral therapy is dependent on the hepatitis C virus genotype
    In: Transplant Infectious Disease, Jg. 20, 2018, Nr. 1, S. e12803
    DOI
  • Durr, M.; Budde, K.; Hofmann, J.; Eisenberger, Ute; Herzer, Kerstin; Sterneck, M.; Gottlieb, J.; Schulz, U.; Halleck, F.
    Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to Five Transplant Recipients : Early Treatment with Direct Acting Antivirals Successfully Prevents HCV-Infection
    In: Transplant International, Jg. 30, 2017, Nr. Suppl. 4 SI, S. 28 Abstract P02
    DOI
  • Halleck, Fabian; Budde, Klemens; Hofmann, Joerg; Eisenberger, Ute; Herzer, Kerstin; Stemeck, Martina; Gottlieb, Jens; Schulz, Uwe; Durr, Michael
    Accidental Transmission of Hepatitis C (HCV) Virus from an Organ Donor to five Transplant Recipients : Early treatment with direct acting Antivrials successfully Prevents Chronic HCV Infection
    In: Transplant International, Jg. 30, 2017, Nr. Suppl. 2 SI, S. 37 - 38 Abstract OS092
    DOI
  • Gliga, S.; Fiedler, Melanie; Herzer, Kerstin; Witzke, Oliver; Krawczyk, Adalbert; Korth, Johannes; Horn, Peter; Dittmer, Ulf; Lindemann, Monika
    CMV elispot assays are superior to the quantiferon CMV assay to predict protection from CMV reactivation in kidney ans liver transplant recipients
    In: HLA: Immune Response Genetics (Human Leukocyte Antigens), Jg. 89, 2017, Nr. 6, S. 375
    DOI
  • Beckebaum, Susanne; Herzer, Kerstin; Bauhofer, A.; Gelson, W.; Desimone, P.; Deman, R.; Mullhaupt, B.; Vionnet, J.; Tisone, G.
    Effectiveness of subcutaneous & intravenous Hepatitis B immunoglobulin to prevent reinfection after liver transplantation : Long-term results from an international multicenter non-interventional study
    In: Transplant International, Jg. 30, 2017, Nr. S2, Special Issue: Abstracts of the 18th Congress of the European Society for Organ Transplantation, 24‐27 September 2017, Barcelona, Spain, S. 40
    DOI
  • Frey, A.; Ecker, E.-M.; Piras-Straub, K.; Walker, Andreas; Hofmann, T.G.; Timm, Jörg; Singer, Bernhard B.; Gerken, Guido; Herzer, Kerstin
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo
    In: Transplantation Proceedings, Jg. 49, 2017, Nr. 8, S. 1947 – 1955
    DOI
  • Forns, Xavier; Berenguer, Marina; Herzer, Kerstin; Sterneck, Martina; Donato, Maria Francesca; Andreone, Pietro; Fagiuoli, Stefano; Cieciura, Tomasz; Durlik, Magdalena; Calleja, Jose Luis; Mariño, Zoe; Shukla, Umesh; Verbinnen, Thierry; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; Peeters, Monika; Janssen, Katrien; Kalmeijer, Ronald; Jessner, Wolfgang
    Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation : The Phase II SATURN study
    In: Transplant Infectious Disease, Jg. 19, 2017, Nr. 3, S. e12696
    DOI
  • Kocabayoglu, Peri; Piras-Straub, Katja; Gerken, Guido; Paul, Andreas; Herzer, Kerstin
    Expression of fibrogenic markers in tumor and tumor-surrounding tissue at time of transplantation correlates with recurrence of hepatocellular carcinoma in patients undergoing liver transplantation
    In: Annals of Transplantation, Jg. 22, 2017, S. 446 – 454
    DOI (Open Access)
  • Eisenberger, Ute; Friebus-Kardash, J.; Guberina, H.; Kribben, Andreas; Witzke, Oliver; Achterfeld, A.; Gerken, Guido; Herzer, Kerstin
    Feasibility of Elabasvir/Grazoprevir for Trearment of Chronic Hepatitis C Virus Infection in Renal Transplant Recipients with Impaired Allograft Function
    In: Transplant International, Jg. 30, 2017, Nr. Suppl 4 SI, S. 28 Abstract P01
    DOI
  • Frey, A.; Walker, A.; Trippler, M.; Gerken, Guido; Herzer, Kerstin
    How do MTOR Inhibitors modulate HCV replication activity : an approach by whole genome analysis
    In: Transplant International, Jg. 30, 2017, Nr. S4, Special Issue: Abstracts of the 26th Annual Meeting of the German Transplantation Society, Bonn, Germany, 25–28 October 2017, S. 38
    DOI
  • Willuweit, Katharina; Heinold, Andreas; Rashidi-Alavijeh, Jassin; Heinemann, Falko M.; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant
    In: Clinical Transplantation, Jg. 31, 2017, Nr. 6, S. e12974
    DOI
  • Herzer, Kerstin; Gerken, Guido; Kroy, D.; Tacke, F.; Plewe, J.; Eurich, D.; Spengler, U.; Strassburg, C. P.; Welker, M. W.; Pischke, S.; Sterneck, M. R.; Mehrabi, A.; Weiss, K. H.; Herber, A.; Berg, T.; Zimmermann, T.; Galle, P. R.; Heinzow, H.; Schmidt, H. H.; von Hahn, T.; Serfert, Y.; Manns, M. P.; Zeuzem, S.; Wedemeyer, Heiner; German Hepatitis C-Registry
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany
    In: Hepatology, Jg. 66, 2017, Nr. S1, Special Issue: The 68th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2017, S. 877A
    DOI
  • Herzer, Kerstin; Gerken, Guido; Kroy, D.; Tacke, F.; Plewe, J.; Eurich, D.; Spengler, U.; Strassburg, C. P.; Welker, M. W.; Pischke, S.; Sterneck, M.; Mehrabi, A.; Weiss, K. H.; Herber, A.; Berg, T.; Zimmermann, T.; Galle, P. R.; Heinzow, H.; Schmidt, H.; von Hahn, T.; Serfert, Y.; Manns, M. P.; Zeuzem, S.; Wedemeyer, Heiner
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany
    In: Transplant International, Jg. 30, 2017, Nr. Suppl. 4, S. 18 – 18
  • Willuweit, K.; Polewsky, L.; Heinold, Andreas; Frey, A.; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Impact of donor specific antibodies following liver transplantation
    In: Transplant International, Jg. 30, 2017, Nr. Suppl. 4, S. 14 – 14
    DOI
  • Willuweit, Katharina; Canbay, Aliekber; Gerken, Guido; Timm, Jörg; Paul, Andreas; Treckmann, Jürgen-Walter; Herzer, Kerstin
    Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics : A re-examination of the situation
    In: Minerva Gastroenterologica e Dietologica, Jg. 63, 2017, Nr. 1, S. 55 – 61
    DOI
  • Herzer, Kerstin; Welzel, Tania M.; Spengler, Ulrich; Hinrichsen, Holger; Klinker, Hartwig; Berg, Thomas; Ferenci, Peter; Peck-Radosavljevic, Markus; Inderson, Akin; Zhao, Yue; Jimenez-Exposito, Maria Jesus; Zeuzem, Stefan
    Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease
    In: Transplant International, Jg. 30, 2017, Nr. 3, S. 243 – 255
    DOI (Open Access)
  • Piras-Straub, K.; Kocabayoglu, P.; Baba, Hideo Andreas; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Sofosbuvir impairs proliferation of hepatocytes in vitro and in vivo
    In: Transplant International, Jg. 30, 2017, Nr. Suppl. 4, S. 17 – 17
  • Eisenberger, Ute; Guberina, Hana; Willuweit, Katharina; Bienholz, Anja; Kribben, Andreas; Gerken, Guido; Witzke, Oliver; Herzer, Kerstin
    Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients
    In: Transplantation, Jg. 101, 2017, Nr. 5, S. 980 – 986
    DOI
  • Halleck, Fabian; Budde, Klemens; Duerr, Michael; Staeck, Oliver; Hofmann, Joerg; Eisenberger, Ute; Herzer, Kerstin; Sterneck, Martina; Gottlieb, Jens; Schulz, Uwe
    Transplanting HCV-infected kidneys into uninfected recipients
    In: The New England Journal of Medicine, Jg. 377, 2017, Nr. 11, S. 1103 – 1104
    DOI, Online Volltext (Open Access)
  • Piras-Straub, Katja; Khairzada, Khaleda; Kocabayoglu, Peri; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    A -1573T>C SNP within the human TRAIL promoter determines TRAIL expression and HCC tumor progression
    In: Cancer Medicine, Jg. 5, 2016, Nr. 10, S. 2942 – 2952
    DOI (Open Access)
  • Hildebrand, Tatiana; Pannicke, Nadine; Dechene, Alexander; Gotthardt, Daniel N; Kirchner, Gabriele; Reiter, Florian P; Sterneck, Martina; Herzer, Kerstin; Lenzen, Henrike; Rupp, Christian; Barg-Hock, Hannelore; de Leuw, Philipp; Teufel, Andreas; Zimmer, Vincent; Lammert, Frank; Sarrazin, Christoph; Spengler, Ulrich; Rust, Christian; Manns, Michael P; Strassburg, Christian P; Schramm, Christoph; Weismüller, Tobias J
    Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis : A retrospective multicenter analysis
    In: Liver Transplantation, Jg. 22, 2016, Nr. 1, S. 42 – 52
    DOI (Open Access)
  • Fontana, Robert; Berg, Christoph; Knop, Viola; Stauber, Rudolf E.; Chacko, Kristina R.; Herzer, Kerstin; Londono, Maria-Carlota; Joshi, Shobha; Prieto, Martin; Moreno-Zamora, Ana
    Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
    In: Liver Transplantation, Jg. 22, 2016, Nr. 4, S. 446 – 458
    DOI (Open Access)
  • Welzel, T. M.; Petersen, J.; Herzer, Kerstin; Ferenci, P.; Gschwantler, M.; Wedemeyer, H.; Berg, T.; Spengler, U.; Weiland, O.; van der Valk, M.; Rockstroh, J.; Peck-Radosavljevic, M.; Zhao, Y.; Jimenez-Exposito, M. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
    In: Gut, Jg. 65, 2016, Nr. 11, S. 1861 – 1870
    DOI (Open Access)
  • Rashidi-Alavijeh, J; Heinold, Andreas; Willuweit, K; Baba, Hideo Andreas; Horn, Peter; Paul, Andreas; Witzke, Oliver; Gerken, Guido; Herzer, Kerstin
    Diagnostics and treatment of a severe humoral rejection after liver transplantation : donor-specific antibodies as a still underestimated cause of graft failure
    In: Zeitschrift für Gastroenterologie, Jg. 54, 2016, Nr. 7, S. 647 – 652
    DOI
  • Forns, Xavier; Samuel, Didier; Mutimer, David; Fagiuoli, Stefano; Navasa, Miquel; Agarwal, Kosh; Berenguer, Marina; Colombo, Massimo; Herzer, Kerstin; Nevens, Frederik; Daems, Bjorn; Janssen, Katrien; Ouwerkerk-Mahadevan, Sivi; Kimko, Holly; Lathouwers, Erkki; Witek, James; van Solingen-Ristea, Rodica
    Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
    In: Annals of Hepatology, Jg. 15, 2016, Nr. 4, S. 512 – 523
  • Zimmermann, T; Beckebaum, Susanne; Berg, C; Berg, T; Braun, F; Eurich, D; Herzer, Kerstin; Neumann, U; Rupp, C; Sterneck, M; Strassburg, C; Welker, M-W; Zachoval, R; Gotthardt, D N; Weigand, K; Schmidt, H; Wedemeyer, H; Galle, P R; Zeuzem, S; Sarrazin, C
    Empfehlungen zur antiviralen Therapie der chronischen Hepatitis C bei Patienten auf der Warteliste und nach Transplantation
    In: Zeitschrift für Gastroenterologie, Jg. 54, 2016, Nr. 7, S. 665 – 684
    DOI
  • Jahn, M.; Herzer, Kerstin; Witzke, Oliver
    Hepatitis C und Nierenerkrankungen
    In: Der Nephrologe, Jg. 11, 2016, Nr. 5, S. 361 – 374
    DOI
  • Herzer, Kerstin; Roeb, Elke
    Modernes Management und neue Herausforderungen bei Fettlebererkrankungen
    In: Klinikarzt, Jg. 45, 2016, Nr. 12, S. 596 – 601
    DOI
  • Herzer, Kerstin; Sterneck, Martina; Nashan, Björn; Zimmermann, T.; Schnitzbauer, Andreas A.; Scherer, Markus N.; Pascher, Andreas; Nadalin, Silvio; Lehner, Frank; Guba, Markus; Engelmann, Cornelius; Braun, Felix; Strassburg, Christian P.
    Selection and use of immunosuppressive therapies after liver transplantation : current German practice
    In: Clinical Transplantation, Jg. 30, 2016, Nr. 5, S. 487 – 501
    DOI
  • Weltermann, Birgitta; Herzer, Kerstin; Herwig, Anna; Dehnen, Dorothea
    Vaccination Status of Pneumococcal and Other Vaccines in 444 Liver Transplant Patients Compared to a Representative Population Sample
    In: Annals of Transplantation, Jg. 21, 2016, S. 200 – 207
    DOI
  • Herzer, Kerstin; Gerken, Guido
    When and How to Treat HCV Infection with the New Antivirals before or after Liver Transplantation
    In: Visceral Medicine, Jg. 32, 2016, Nr. 4, S. 258 – 262
    DOI, Online Volltext (Open Access)
  • Reis, Henning; Wohlschläger, Jeremias; Hagemann, Sascha; Wenzel, Patricia; Bechmann, Lars Peter; Suttorp, Anna-Carinna; Schlattjan, Martin J; Herzer, Kerstin; Canbay, Aliekber; Baba, Hideo Andreas
    (Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts
    In: Liver International, Jg. 35, 2015, Nr. 3, S. 905 – 913
    DOI
  • Piras-Straub, K.; Paul, A.; Gerken, Guido; Herzer, Kerstin
    A GATA-1 binding site mutation leads to reduced TRAIL expression in human HCC
    In: Journal of Viral Hepatitis, Jg. 22, 2015, Nr. S2, S. 131
    DOI
  • Herzer, Kerstin; Welzel, T. M.; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; van der Valk, M.; Klinker, H.; Rockstroh, J. K.; Schott, E.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Daclatasvir in combination with sofosbuvir with or without ribavirin is safe and efficacious in liver transplant recipients with HCV recurrence : Interim results of a multicenter compassionate use program
    In: Hepatology, Jg. 62, 2015, Nr. S1, S. 341A
    DOI
  • Welzel, T. M.; Herzer, Kerstin; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Van der Valk, M.; Klinker, H.; Rockstroh, J.; Ingiliz, P.; Peck-Radosavljevic, M.; Jimenez-Exposito, M. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease : Interim results of a multicenter compassionate use program
    In: Journal of Hepatology, Jg. 62, 2015, Nr. Suppl. 2, S. 619 – S620
    DOI
  • Welzel, T.; Herzer, Kerstin; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Van der Valk, M.; Klinker, H.; Rockstroh, J.; Ingiliz, P.; Peck-Radosavljevic, M.; Jimenez-Exposito, M. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease : interim results of a compassionate use program
    In: Journal of Viral Hepatitis, Jg. 22, 2015, Nr. Suppl. 3, S. 4 – 5
    DOI
  • Rockstroh, J. K.; Welzel, T. M.; Ingiliz, P.; Petersen, J.; van der Valk, M.; Herzer, Kerstin; Ferenci, P.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Klinker, H.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV in patients coinfected with HIV : Interim results of a multicenter compassionate use program
    In: Hepatology, Jg. 62, 2015, Nr. Suppl. 1, S. 728A – 729A
    DOI
  • Herzer, Kerstin; Papadopoulos-Köhn, Angela; Walker, Andreas; Achterfeld, Anne; Paul, Andreas; Canbay, Aliekber; Timm, Jörg; Gerken, Guido
    Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant
    In: Digestion, Jg. 91, 2015, Nr. 4, S. 326 – 333
    DOI
  • Papadopoulos-Köhn, Angela; Achterfeld, Anne; Paul, Andreas; Canbay, Aliekber; Timm, Jörg; Jochum, Christoph; Gerken, Guido; Herzer, Kerstin
    Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant
    In: Transplantation, Jg. 99, 2015, Nr. 4, S. 841 – 847
    DOI (Open Access)
  • Schumann, Alexandra; Fiedler, Melanie; Beckebaum, Susanne; Cicinnati, Vito; Herzer, Kerstin; Lenz, Veronika; Witzke, Oliver; Paul, Andreas; Roggendorf, Michael; Horn, Peter; Lindemann, Monika
    Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantation
    In: Human Immunology, Jg. 76, 2015, Nr. 9, S. 631 – 635
    DOI
  • Piras-Straub, Katja; Khairzada, Khaleda; Gerken, Guido; Saner, Fuat; Treckmann, Jürgen-Walter; Paul, Andreas; Canbay, Aliekber; Herzer, Kerstin
    Glutamate Dehydrogenase and Alkaline Phosphatase as Very Early Predictors of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    In: Digestion, Jg. 91, 2015, Nr. 2, S. 117 – 127
    DOI
  • Frey, A.; Ecker, E. M.; Piras-Straub, K.; Walker, Andreas; Hofmann, T.; Gerken, Guido; Herzer, Kerstin
    HCV replication activity is modified by mTor-inhibitors in vitro which is mediated by PML
    In: Journal of Viral Hepatitis, Jg. 22, 2015, Nr. Suppl. 2, S. 69 – 70
    DOI
  • Herzer, Kerstin; Gerken, Guido
    Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents
    In: World Journal of Hepatology, Jg. 7, 2015, Nr. 3, S. 532 – 538
    DOI
  • Herzer, Kerstin; Papadopoulos-Köhn, Angela; Achterfeld, Anne; Canbay, Aliekber; Piras-Straub, Katja; Paul, Andreas; Walker, Andreas; Timm, Jörg; Gerken, Guido
    Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant
    In: World Journal of Hepatology, Jg. 7, 2015, Nr. 9, S. 1287 – 1296
    DOI
  • Forns, X.; Berenguer, M.; Herzer, Kerstin; Sterneck, M.; Donato, M. F.; Andreone, P.; Fagiuoli, S.; Cieciura, T.; Durlik, M.; Calleja, J. L.; Marino, Z.; Simion, A.; Shukla, U.; Verbinnen, T.; Lenz, O.; Ouwerkerk-Mahadevan, S.; Peeters, M.; Kalmeijer, R.; Witek, J.
    On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT) : Interim data from the phase II saturn study
    In: Journal of Hepatology, Jg. 62, 2015, Nr. Suppl. 2, S. S 191 - S192
    DOI
  • Welzel, T. M.; Petersen, J.; Ferenci, P.; Gschwantler, M.; Herzer, Kerstin; Cornberg, M.; Schott, E.; Berg, T.; Spengler, U.; Weiland, O.; van der Valk, M.; Geier, A.; Rockstroh, J. K.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Safety and efficacy of daclatasvir plus sofosbuvir with or without ribavirin for the treatment of chronic HCV genotype 3 infection : Interim results of a multicenter European compassionate use program
    In: Hepatology, Jg. 62, 2015, Nr. S1, S. 225A – 226A
    DOI
  • Piras-Straub, Katja; Khairzada, Khaleda; Trippler, Martin; Baba, Hideo Andreas; Kaiser, Gernot Maximil; Paul, Andreas; Canbay, Aliekber; Weber, Frank; Gerken, Guido; Herzer, Kerstin
    TRAIL expression levels in human hepatocellular carcinoma have implications for tumor growth, recurrence and survival
    In: International Journal of Cancer, Jg. 136, 2015, Nr. 4, S. E154 – E160
    DOI (Open Access)
  • Frey, A.; Ecker, E. M.; Piras-Straub, K.; Walker, A.; Hofmann, T.; Gerken, Guido; Herzer, Kerstin
    The tumor suppressor PML mediates everolimus- induced changes of the HCV replication activity
    In: Journal of Hepatology, Jg. 62, 2015, Nr. Suppl. 2, S. 582
    DOI
  • Herzer, Kerstin; Gerken, Guido
    Therapie der Hepatitis C bei Patienten mit Zirrhose sowie vor und nach Lebertransplantation
    In: Der Gastroenterologe, Jg. 10, 2015, Nr. 4, S. 297 – 304
    DOI
  • Herzer, Kerstin; Gerken, Guido; Hoffmann, Thomas
    Hepatitis C-associated liver carcinogenesis : Role of PML nuclear bodies
    In: World Journal of Gastroenterology, Jg. 20, 2014, Nr. 35, S. 12367 – 12371
    DOI (Open Access)
  • Kahraman, Alisan; Herzer, Kerstin
    Laboratory monitoring after liver transplantation
    In: Der Gastroenterologe, Jg. 9, 2014, Nr. 2, S. 112 – 116
    DOI
  • Hilgard, Philip Alexander; Dechene, Alexander; Canbay, Aliekber; Herzer, Kerstin; Schlaak, Jörg Friedrich; Treichel, Ulrich; Gassel, Andrea M.; Baba, Hideo Andreas; Zöpf, Thomas
    Mini-laparoscopy is superior in detecting liver cirrhosis and metastases in liver cancer : an over 10-year experience in 1,788 cases
    In: Digestion, Jg. 89, 2014, Nr. 2, S. 156 – 164
    DOI
  • Amrillaeva, V.; Hoyer, D.; Gallinat, Anja; Herzer, Kerstin; Canbay, Aliekber; Treckmann, Jürgen-Walter; Mathe, Zoltan; Paul, Andreas; Saner, Fuat
    Retransplantation for Hepatitis C Recurrence : Should We Do It?
    In: American Journal of Transplantation, Jg. 14, 2014, Nr. Suppl. 3, S. 705
    DOI
  • Teufel, A.; Sarrazin, C.; Pannicke, N.; Kirchner, G.; Zimmer, V.; Lenzen, Henrike; Schramm, C.; Weismüller, T.J.; Rust, C.; Lammert, F.; de Leuw, P.; Horn, T.; Dechene, Alexander; Sterneck, M.; Reiter, F.P.; Strassburg, C.P.; Herzer, Kerstin; Gotthardt, D.; Manns, M.P.; Barg-Hock, H.; Spengler, Ulf
    Biliary strictures and recurrent disease after liver transplantation for primary sclerosing cholangitis - a large, multicenter cohort analysis with long-term follow-up
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S42 – S43
    DOI
  • Herzer, Kerstin; Papadopoulos-Kohn, A.; Buchter, M.; Canbay, Aliekber; Paul, Andreas; Jochum, Christoph; Gerken, Guido
    Daily low-dose Tacrolimus (TAC) is a save and efficient immunosuppressive regimen during triple drug therapy post liver transplant
    In: Der Internist, Jg. 54, 2013, Nr. Suppl. 1, S. 32 – 33
  • Herzer, Kerstin; Papadopoulos-Köhn, A.; Paul, Andreas; Gerken, Guido
    Daily low-dose tacrolimus (TAC) is a safe and efficient immunosuppressive regimen during HCV triple drug therapy post liver transplant - A 24 weeks interim analysis
    In: Transplant International, Jg. 26, 2013, Nr. Suppl. 1, S. 6
  • Fingas, Christian; Altinbas, Akif; Schlattjan, Martin; Beilfuss, Anja; Sowa, Jan-Peter; Sydor, Svenja; Bechmann, Lars Peter; Ertle, Judith; Akkiz, Hikmet; Herzer, Kerstin; Paul, Andreas; Gerken, Guido; Baba, Hideo Andreas; Canbay, Aliekber
    Expression of apoptosis- and vitamin D pathway-related genes in hepatocellular carcinoma
    In: Digestion, Jg. 87, 2013, Nr. 3, S. 176 – 181
    DOI
  • Kirchner, G.; Herzer, Kerstin; Horn, T.; Spengler, Ulf; Gotthardt, D.; Manns, M.P.; Strassburg, C.P.; Pannicke, N.; Lenzen, Henrike; Dechene, Alexander; Schramm, C.; Barg-Hock, H.; Sterneck, M.; Weismüller, T.J.
    Extrahepatic malignancies after liver transplantation for primary sclerosing cholangitis - a long-term follow-up observational study of a large, multicenter cohort
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S395
    DOI
  • Herzer, Kerstin; Papadopoulos-Köhn, Angela; Timm, Jörg; Paul, Andreas; Jochum, Christoph; Gerken, Guido
    HCV-Reinfektion nach Lebertransplantation : Management und erste Ergebnisse mit der Telaprevir-basierten Triple-Therapie
    In: Deutsche Medizinische Wochenschrift - DMW, Jg. 138, 2013, Nr. 36, S. 1759 – 1764
    DOI
  • Herzer, Kerstin; Paul, Andreas; Gerken, Guido
    Lebertransplantation - Wo stehen wir heute?
    In: Deutsche Medizinische Wochenschrift - DMW, Jg. 138, 2013, Nr. 28-29, S. 1471 – 1477
    DOI
  • Krawczyk, Adalbert; Roggendorf, Hedwig; Ludwig, Charlotte; Herzer, Kerstin; Gerken, Guido; Horn, Peter; Roggendorf, Michael; Lindemann, Monika
    Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy
    In: Liver Transplantation, Jg. 19, 2013, Nr. 12, S. 1411 – 1412
    DOI
  • Herzer, Kerstin; Carbow, Anna; Sydor, Svenja; Sowa, Jan-Peter; Biesterfeld, Stefan; Hofmann, Thomas-Georg; Galle, Peter-Robert; Gerken, Guido; Canbay, Aliekber
    Deficiency of the Promyelocytic Leukemia Protein Fosters Hepatitis C-Associated Hepatocarcinogenesis in Mice
    In: PLoS ONE, Jg. 7, 2012, Nr. 9, S. e44474
    DOI (Open Access)
  • Herzer, K.; Müller, Stefan; Antoch, G.; Hilgard, Philip Alexander
    Locoregional therapy for hepatocellular carcinoma : Radioembolization with yttrium-90 microspheres
    In: Minerva Gastroenterologica e Dietologica, Jg. 57, 2011, Nr. 3, S. 287 – 298
  • Ertle, Judith; Dechene, Alexander; Sowa, Jan-Peter; Penndorf, Volker; Herzer, Kerstin; Kaiser, Gernot Maximil; Schlaak, Jörg Friedrich; Gerken, Guido; Syn, Wing-Kin; Canbay, Aliekber
    Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
    In: International Journal of Cancer, Jg. 128, 2011, Nr. 10, S. 2436 – 2443
    DOI
  • Herzer, Kerstin; Kneiseler, Guntje; Bechmann, Lars Peter; Post, Felix; Schlattjan, Martin; Sowa, Jan-Peter; Neumann, Till; Marggraf, Günter; Erbel, Raimund; Gerken, Guido; Canbay, Aliekber; Jochum, Christoph
    Onset of heart failure determines the hepatic cell death pattern
    In: Annals of Hepatology, Jg. 10, 2011, Nr. 2, S. 174 – 179
    DOI, Online Volltext (Open Access)
  • Wree, Alexander; Dechene, Alexander; Herzer, Kerstin; Hilgard, Phillip; Syn, Wing-Kin; Gerken, Guido; Canbay, Aliekber
    Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
    In: Digestion, Jg. 84, 2011, Nr. 1, S. 54 – 59
    DOI
  • Kneiseler, G.; Herzer, Kerstin; Marggraf, Günter; Gerken, Guido; Canbay, Aliekber
    Die Interaktion zwischen Leber und Herz
    In: Zeitschrift für Herz-, Thorax- und Gefäßchirurgie (ZHTG), Jg. 24, 2010, Nr. 6, S. 334 – 340
    DOI
  • Herzer, Kerstin; Post, F.; Canbay, Aliekber; Gerken, Guido
    Pulmonale Affektion bei fortgeschrittener Lebererkrankung – hepatopulmonales Syndrom und portopulmonale Hypertonie
    In: Medizinische Klinik, Jg. 105, 2010, Nr. 12, S. 916 – 923
    DOI

    • Vorworte / Nachworte

  • Herzer, Kerstin; Fingas, Christian; Canbay, Aliekber
    Does ursodeoxycholic acid exert a protective effect on liver grafts in orthotopic liver transplantation?
    In: Digestion. Basel: Karger, Jg. 86, 2012, Nr. 3, S. 206 – 207
    DOI

    • Abstracts

  • Hagemann, A.; Husen, P.; Straub, K.; Willuweit, Katharina; Wedemeyer, Heiner; Bachmann, Hagen Sjard; Herzer, Kerstin
    MTOR polymorphisms and de novo diabetes mellitus in liver transplantation patients treated with everolimus
    87th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) ; 1 March – 3 March 2021, Digital,
    In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 394, 2021, Nr. Suppl. 1, S. S25
    DOI (Open Access)
  • Frey, A.; Trippler, Martin; Gerken, Guido; Herzer, Kerstin
    CCNT1 mediates mTor inhibitor related antiviral effects in HCV genotype 2a
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 68, 2018, Nr. Suppl. 1, S. 136
    DOI
  • Knop, Viola; Mauss, Stefan; Goeser, Tobias; Geier, Andreas; Zimmermann, Tim; Herzer, Kerstin; Postel, Nils; Hofmann, Wolf Peter
    Dynamics of Liver Stiffness By Transient Elastography in Patients with Chronic Hepatitis C (HCV) Infection Receiving Direct Acting Antiviral Therapy-Results from the German Hepatitis C-Registry (DHC-R)
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 68, 2018, Nr. Suppl. 1, S. 424A
    DOI
  • Friebus-Kardash, J.; Gäckler, Anja; Kribben, Andreas; Witzke, Oliver; Wedemeyer, Heiner; Treckmann, Jürgen-Walter; Herzer, Kerstin; Eisenberger, Ute
    Successful early treatment of HCV viremia after transplantation of HCV positive renal allografts into HCV negative recipients
    27th Annual Meeting of the German Transplantation Society, Berlin, Germany, 7–10 November 2018,
    In: Transplant International. Lausanne: Frontiers Media, Jg. 31, 2018, Nr. Suppl. 5, S. 11
  • Bedreli, Sotiria; Piras-Straub, K.; Achterfeld, Anne; Katsounas, Antonios; Saner, Fuat; Gerken, Guido; Herzer, Kerstin
    The effect of immunosuppression on coagulation in patients after liver transplantation
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 68, 2018, Nr. Suppl. 1, S. 386 – S387
    DOI
  • Eisenberger, Ute; Friebus-Kardash, Justa; Rohn, Hana; Kribben, Andreas; Witzke, Oliver; Gäckler, Anja; Willuweit, Katharina; Gerken, Guido; Herzer, Kerstin
    Treatment with Grazoprevir/Elbasvir for renal transplant recipients with chronic Hepatitis C Virus Infection and impaired allograft function
    In: Nephrology Dialysis Transplantation (NDT). Oxford: Oxford University Press (OUP), Jg. 33, 2018, Nr. Suppl_1, S. i602 – i603
    DOI (Open Access)
  • Herzer, Kerstin; Welzel, T.; Ferenci, P.; Petersen, J.; Gschwantler, M.; Cornberg, M.; Berg, T.; Spengler, U.; Weiland, O.; Van der Valk, M.; Klinker, H.; Rockstroh, J.; Schott, E.; Peck-Radosavljevic, M.; Zhao, Y.; Exposito, M. J. J.; Zeuzem, S.
    Daclatasvir plus Sofosbuvir +/- Ribavirin in Liver Transplant Recipients with HCV Recurrence : Interim Results of a European Multicenter Compassionate Use Program
    In: Transplantation. Philadelphia: Lippincott Williams & Wilkins, Jg. 100, 2016, Nr. Suppl. 5, S. 181
    DOI
  • Willuweit, K.; Heinold, Andreas; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Donor specific antibodies post liver transplant : Predictors and protectors
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 64, 2016, Nr. 2, Suppl., S. S544
    DOI
  • Willuweit, K.; Heinold, Andreas; Horn, Peter; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Predictors and protectors of donor specific antibodies after liver transplantation
    In: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, S. 22
    DOI
  • Willuweit, K.; Heinold, Andreas; Horn, Peter; Gerken, Guido; Paul, Andreas; Herzer, Kerstin
    Predictors for the Development of Donor Specific Antibodies After Liver Transplantation
    In: Transplantation. Philadelphia: Lippincott Williams & Wilkins, Jg. 100, 2016, Nr. Suppl. 5, S. 238
    DOI
  • Guberina, Hana; Eisenberger, Ute; Willuweit, K.; Bienholz, Anja; Kribben, Andreas; Gerken, Guido; Witzke, Oliver; Herzer, Kerstin
    Successful therapy of chronic hepatitis C virus infectionwith sofosbuvir and ledipasvir in renal transplant recipients
    In: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, S. 20 – 21
    DOI
  • Weltermann, Birgitta; Herwig, A.; Dehnen, Dorothea; Herzer, Kerstin
    Impfstatus von Patienten nach Lebertransplantation – Eine Querschnittsstudie
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist. Berlin: Springer Medizin, Jg. 56, 2015, Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 64
    DOI
  • Herzer, Kerstin; Welzel, T.; Spengler, U.; Hinrichsen, H.; Umgelter, A.; Gruner, N.; Klass, D.; Wiegand, J.; Zimmermann, T.; Fueloep, B.; Tacke, F.; Exposito, M. J. J.; Zeuzem, S.
    Safety and efficacy of daclatasvir plus sofosbuvir with or without ribarivin for hepatitis C post-transplant : interim results from the compassionate use program
    24th Annual Meeting of the German Transplantation Society, 22–24 October 2015, Dresden, Germany,
    In: Transplant International. Lausanne: Frontiers Media, Jg. 28, 2015, Nr. Suppl. 2, S. 35
    DOI
  • Papadopoulos-Kohn, A.; Timm, Jörg; Canbay, Aliekber; Jochum, Christoph; Paul, Andreas; Gerken, Guido; Herzer, Kerstin
    Daclatasvir, Simeprevir and Ribavirin as a new IFN-free triple regimen for HCV recurrence after liver transplantation : First results of safety and efficacy in 6 patients
    23rd Annual Meeting of the German Transplantation Society, Mannheim, Germany, 16–18 October 2014,
    In: Transplant International. Lausanne: Frontiers Media, Jg. 27, 2014, Nr. Suppl. 3, S. 19
    DOI
  • Papadopoulos-Kohn, A.; Timm, Jörg; Canbay, Aliekber; Jochum, Christoph; Gerken, Guido; Herzer, Kerstin
    Daclatasvir, Simeprevir and Ribavirin as a new IFN-free triple regimen for HCV recurrence after liver transplantation : First results of safety and efficacy in 6 patients
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 60, 2014, Nr. Suppl. 1, S. 697A
    DOI (Open Access)
  • Herzer, Kerstin; Mederacke, I.; Gerken, Guido; Lehner, F.; Klempnauer, J.; Manns, M. P.; Wursthorn, K.
    Reinfection prophylaxis with entecavir monotherapy is successful and safe in patients with hepatitis B virus infection after liver transplantation
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 60, 2014, Nr. Suppl. 1, S. 538A
    DOI
  • Ecker, E. M.; Frey, A.; Piras-Straub, K.; Walker, A.; Gerken, Guido; Herzer, Kerstin
    The influence of mTor-Inhibitors on HCV replication after liver transplantation
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 60, 2014, Nr. Suppl. 1, Special Issue: The 65th Annual Meeting of the American Association for the Study of Liver Diseases, S. 533A
    DOI